Get the Stockscreener App
6.93
3.48%
-0.25
Bionexus Gene Lab Corp stock is traded at $6.93, with a volume of 947.20K.
It is down -3.48% in the last 24 hours and up +125.73% over the past month.
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
See More
Previous Close:
$7.18
Open:
$6.58
24h Volume:
947.20K
Relative Volume:
0.50
Market Cap:
$12.45M
Revenue:
$9.26M
Net Income/Loss:
$-941.60K
P/E Ratio:
-96.25
EPS:
-0.072
Net Cash Flow:
$-2.65M
1W Performance:
+42.01%
1M Performance:
+125.73%
6M Performance:
+70.06%
1Y Performance:
+42.10%
1-Day Range:
$6.20
$7.21
1-Week Range:
$4.40
$8.98
52-Week Range:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.6285 | 833.82M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.13 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.80 | 115.41M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.151 | 324.25M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.765 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
Bionexus Gene Lab Corp. shares fall 4.60% premarket despite announcing a strategic partnership with Fidelion Diagnostics. - AInvest
Key metrics from BioNexus Gene Lab Corp.’s quarterly dataFree Chart Breakout Buy Signal Detection - Newser
Any catalyst today for BGLC - AInvest
Visualizing BioNexus Gene Lab Corp. stock with heatmapsMomentum Prediction Based on AI Backtesting - Newser
Sentiment analysis tools applied to BioNexus Gene Lab Corp.Sector Rotation and Stock Opportunity Analysis - Newser
Mag 7 Undercard: REPL, BGLC, TYGO, SGD – More Stocks Inside Heating Up Now! - FinancialContent
BGLC signs non-binding pact for exclusive MRD test rights in SE Asia | BGLC SEC FilingForm 8-K - Stock Titan
US Stocks Edge Higher; Kraft Heinz Earnings Top Views - Benzinga
BioNexus Gene Lab’s Unexpected Surge - StocksToTrade
BioNexus Gene Lab Corp: Stock Soars, Opportunity or No? - timothysykes.com
Bionexus Gene Lab, Fidelion sign term sheet for partnership - TipRanks
BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance-Touted as a new 'DeepSeek Moment” in Precision Oncology - The Manila Times
Revolutionary Cancer Detection Tech Cuts Testing Costs 90% Through BioNexus-Fidelion Alliance | BGLC Stock News - Stock Titan
Using Bollinger Bands to evaluate BioNexus Gene Lab Corp.Chart Driven Opportunity Scanner with Alerts - Newser
Developing predictive dashboards with BioNexus Gene Lab Corp. dataPredictive Model for Intraday Swing Forecast - Newser
Using flow based indicators on BioNexus Gene Lab Corp.Free ROI Driven Equity Selection With Safety - Newser
What data driven models say about BioNexus Gene Lab Corp.’s futureReal Time Screener for Growth Trades - Newser
Price Floor Holding on BioNexus Gene Lab Corp. — Rebound PossibleMarket Entry and Exit Point Tips From Traders - metal.it
Is BioNexus Gene Lab Corp. a candidate for recovery play2-Day Signal Watch with Forecast Outcome - Newser
Will Volume Confirm Reversal in BioNexus Gene Lab Corp.Market Momentum Signal Generator Shows Trends - metal.it
Can BioNexus Gene Lab Corp. Regain Lost Ground This QuarterTrend Analysis for Safer Trades Gains Popularity - metal.it
Has BioNexus Gene Lab Corp. Stock Ever Crashed Historical Volatility ReviewEntry and Exit Strategy Optimizer Tool Tested - metal.it
What makes BioNexus Gene Lab Corp. stock price move sharplyMulti-Year Signal Summary and Entry Timing - Newser
How Resilient Is BioNexus Gene Lab Corp. Stock During Economic DownturnsMomentum Screener with Buy and Sell Areas - Newser
Top chart patterns to watch in BioNexus Gene Lab Corp.Free Buy Signal Based on Chart Analysis - Newser
What is the dividend policy of BioNexus Gene Lab Corp. stockRapid growth trajectories - jammulinksnews.com
How does BioNexus Gene Lab Corp. generate profit in a changing economyMaximize portfolio growth with strategic plans - jammulinksnews.com
Will earnings trigger a reversal in Mersana Therapeutics Inc.Controlled Entry Strategy With Safety Analytics - Newser
Published on: 2025-07-31 02:21:55 - Newser
Reversal indicators forming on BioNexus Gene Lab Corp. stock Free Low Drawdown Real Time Trading Tips - Newser
Is it the right time to buy BioNexus Gene Lab Corp. stockTrack emerging stocks with high growth potential - jammulinksnews.com
Is BioNexus Gene Lab Corp. stock overvalued or undervaluedFree Bull & Bear Market Updates - jammulinksnews.com
What analysts say about BioNexus Gene Lab Corp. stockGame-changing returns - PrintWeekIndia
Is BioNexus Gene Lab Corp. a good long term investmentDynamic investment opportunities - PrintWeekIndia
BioNexus Gene Lab Corp. Stock Analysis and ForecastUnmatched profit potential - PrintWeekIndia
What drives BioNexus Gene Lab Corp. stock priceFree Investment Case Studies - jammulinksnews.com
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - Benzinga
What latest new for bglc - AInvest
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):